Procter & Gamble Health Limited Stock

Equities

PGHL

INE199A01012

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:49 2024-04-29 EDT 5-day change 1st Jan Change
4,774 INR +1.06% Intraday chart for Procter & Gamble Health Limited +1.64% -3.47%

Financials

Sales 2022 11.14B 134M 182M Sales 2023 12.3B 147M 201M Capitalization 87.13B 1.04B 1.43B
Net income 2022 1.92B 23.08M 31.5M Net income 2023 2.3B 27.52M 37.56M EV / Sales 2022 5.95 x
Net cash position 2022 3.17B 37.96M 51.81M Net cash position 2023 4.23B 50.72M 69.23M EV / Sales 2023 6.74 x
P/E ratio 2022
36.1 x
P/E ratio 2023
38 x
Employees 1,407
Yield 2022
1.25%
Yield 2023
1.81%
Free-Float 47.83%
More Fundamentals * Assessed data
Dynamic Chart
Procter & Gamble Health Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024 CI
Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024 CI
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Procter & Gamble Hygiene to Discontinue Injection Production at Goa, Unit, India MT
Procter & Gamble Health Limited Discontinues Production of Injections at its Manufacturing Plant in Goa Effective September 30, 2023 CI
Procter & Gamble Health's Net Profit Slumps in Fiscal Q4; Shares Dip 5% MT
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the Fourth Quarter Ended June 30, 2023 CI
Procter & Gamble Health Limited Recommends Final Dividend,Payable Between November 28, 2023 to December 18, 2023 CI
Procter & Gamble Health Limited Announces Change in Senior Management Personnel CI
Procter & Gamble India to invest $244 million to set up manufacturing facility RE
Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Procter & Gamble Health Appoints CFO MT
Procter & Gamble Health Limited Appoints Lokesh Chandak as Chief Financial Officer, Effective April 1, 2023 CI
More news
1 day+1.06%
1 week+1.64%
Current month+1.44%
1 month+1.44%
3 months-9.39%
6 months-6.04%
Current year-3.47%
More quotes
1 week
4 643.65
Extreme 4643.65
4 814.40
1 month
4 643.65
Extreme 4643.65
4 834.90
Current year
4 643.65
Extreme 4643.65
5 640.00
1 year
4 600.00
Extreme 4600
5 640.00
3 years
3 883.00
Extreme 3883
6 434.15
5 years
2 927.80
Extreme 2927.8
7 499.95
10 years
615.00
Extreme 615
7 499.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 18-03-31
Director of Finance/CFO - 23-03-31
Compliance Officer - 21-06-30
Members of the board TitleAgeSince
Chairman 86 84-01-16
Director/Board Member 66 21-11-14
Director/Board Member 75 15-02-04
More insiders
Date Price Change Volume
24-04-29 4,774 +1.06% 458
24-04-26 4,724 +0.08% 354
24-04-25 4,721 -0.33% 492
24-04-24 4,736 +0.54% 239
24-04-23 4,711 +0.23% 766

Delayed Quote Bombay S.E., April 29, 2024 at 06:00 am

More quotes
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company’s brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.
More about the company

Annual profits - Rate of surprise